Alopexx, Inventages co-lead more than $15 mln funding in Cognoptix
Alopexx and Inventages have co-led the first $15 million first tranche of a Series D funding round in Cognoptix, which is developing an eye test to identify Alzheimer's Disease. Launchpad Venture Group, Cognoptix's original investor, also participated in the funding.
1 October 2014•2 mins read
